Skip to main content

What are you looking for?

Write the name, title or any keyword related to what you are looking for and select which content category it belongs to.

Activities

Jornada 'Nano World Cancer Day 2025'

09:30 Benvinguda i Inauguració Josep Samitier · Coordinador Científic de NANOMED Spain Begoña Benito · Directora del VHIR 09:40 Nanomedicina i càncer Josep Samitier · Coordinador Científic de NANOMED Spain 10:00 Fernanda Raquel Da Silva Andrade · Principal Inves

Activities

Presentació Pública del projecte DoCTIS

Presentació dels resultats dels cinc anys del projecte DoCTIS a pacients, familiars i tota persona interessada.  DoCTIS és un projecte europeu que busca noves combinacions de fàrmacs ja aprovats per tractar sis de les malalties inflamatòries immunomediades més comune: artritis reum

Activities

Vall d'Hebron Talks by VHIR 'Leveraging diffusion-weighted magnetic resonance imaging to characterise inflammation and degeneration along the lifespan'

Speaker: Dr. Silvia De Santis, Group leader Translational Imaging Biomarkers. Instituto de Neurociencias (CSIC-UMH), San Juan de Alicante, Spain Abstract: Neuroinflammation and neurodegeneration are hot topics for brain research, and promising targets for the development of novel treatm

Activities

Jornada Dia Mundial Contra el Càncer

Segueix la jornada online en aquest enllaç: https://gencat.zoom.us/j/81665155590

News

The second call for proposals for the European TOUCH program is open, with two VHIR projects participating

The doctoral training program of excellence led by the UAB TOUCH MSCA-COFUND, focused on the field of mental health, opens its second call until March 31.

Activities

Pedaleando por la ELA

Pedaleando por la ELA is a solidarity project led by Antonio Tejada, aimed at raising awareness of the fight against Amyotrophic Lateral Sclerosis (ALS). In April 2025, Antonio and fellow cyclists from the CC Plana Lladó Cycling Club will ride from Vall d’Hebron Hospital to the Santiago de Compos

Activities

Defensa de Tesi 'Noves estratègies neuroprotectores després de l'ictus isquèmic'

Doctoranda: Paula García Rodríguez, grup de Recerca de Malalties neurovasculars (VHIR) Director:  Dr. Juan Bernardo Montaner Villalonga Tutor: Dr. Juan Bernardo Montaner Villalonga

News

VHIR launches an online 'Animal Model Search Engine'

VHIR presents an innovative tool that streamlines the search for animal models, fostering collaboration between researchers and advancing scientific research based on the principles of the 3Rs.

News

The Vall d'Hebron Accredited Institute has received the most R&D&I projects in the field of health from the Carlos III Health Institute, amounting to more than 8 million euros

Within the framework of the Strategic Action in Health 2024 call, funding has also been granted for two other projects in calls for Technological Development in Health and Independent Clinical Research.

News

Vall d'Hebron proposes hyperthermic therapy with magnetic nanoparticles to improve treatment of pancreatic cancer with adenocarcinoma

Based on the study led by VHIR, a clinical trial has been approved for patients with locally advanced pancreatic cancer.

News

Project-COMFORT launches to revolutionize patient-centric blood collection

Vall d'Hebron participates in a project to develop innovative microsampling technology, making blood collection more accessible and patient-centred.

News

A study has developed an innovative model to predict left ventricular thrombus after acute myocardial infarction

The study, which involved Vall d'Hebron, developed an action plan to efficiently allocate resources to patients most at risk of suffering this complication.

News

Analysis of placental biomarkers in blood in pregnancies with growth retardation avoids unnecessary labor inductions and reduces complications

A study led by Dr. Manel Mendoza from Vall d’Hebron shows that studying the levels of placental markers is as effective as Doppler ultrasounds, the standard method for classifying the risk of pregnancies with low birth weight fetuses.

Activities

Vall d'Hebron Talks by VHIR 'Unveiling Epigenomic Vulnerabilities in Diffuse Midline Glioma: Paving the Way for Innovative Therapeutic Approaches'

Speaker: Dr. Fátima Valdés Mora. Head research group Cancer Epigenetic Biology and Therapeutics, Children’s Cancer Institute. Sydney Abstract: Diffuse midline glioma (DMG) is the most aggressive brain tumour in children, with a median survival of less than one year and with

Activities

Vall d'Hebron Talks by VHIR 'In vitro evolution of nucleic acids: from the origin of life to its biomedical applications'

Speaker; Dr. Carlos Briones, Laboratory of Molecular Evolution- Center for Astrobiology (CSIC-INTA, Associated with the NASA Astrobiology Program) One of the main scientific questions is how life began on Earth... or perhaps on any other planet or satellite. The first scientific reflect

News

Vall d’Hebron participates in a consensus to optimize equity in access to liver transplant

The consensus establishes recommendations that could correct the current disparities related to muscle mass, weight and height and would allow for more precise prioritization of patients who require transplants more urgently.

Activities

Vall d'Hebron Talks by VHIR 'Supervivència al càncer de mama. Perspectiva de la pròpia dona supervivent'

Ponent: Elena Torralba Martínez. Infermera graduada per la Universitat de València. Els darrers deu anys he combinat la meva principal activitat com infermera assistencial, amb col·laboracions docents i participació en recerca. En aquest sentit he tutoritzat treballs fi de grau, treballs fi de mà

News

The second edition of a citizen science project involving Parkinson's patients and teenagers has come to an end

The initiative seeks to raise awareness of the disease and promote the well-being of those affected, while fostering empathy and scientific vocations among young people.

News

Mi Compañero de Viaje adds a decade of donations in the fight against childhood and adolescent cancer research

L’associació, un any més, ha mostrat el seu compromís amb la recerca oncològica amb un donatiu de 19.197 € al grup de recerca de Càncer i Malalties Hematològiques Infantils del VHIR.

News

Pre-registration is now open for the VHIR master's degrees

You can now register for the Master's Degree in Translational Biomedical Research, the Master's Degree in Clinical Trial Management and Coordination and, as a novelty, the Master's Degree in Health Innovation and Entrepreneurship.